Document Detail


A novel Phex mutation in a new mouse model of hypophosphatemic rickets.
MedLine Citation:
PMID:  22573557     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
X-linked hypophosphatemic rickets (XLH) is a dominantly inherited disease characterized by renal phosphate wasting, aberrant vitamin D metabolism, and defective bone mineralization. It is known that XLH in humans and in certain mouse models is caused by inactivating mutations in PHEX/Phex (phosphate-regulating gene with homologies to endopeptidases on the X chromosome). By a genome-wide N-ethyl-N-nitrosourea (ENU)-induced mutagenesis screen in mice, we identified a dominant mouse mutation that exhibits the classic clinical manifestations of XLH, including growth retardation, skeletal abnormalities (rickets/osteomalacia), hypophosphatemia, and increased serum alkaline phosphatase (ALP) levels. Mapping and sequencing revealed that these mice carry a point mutation in exon 14 of the Phex gene that introduces a stop codon at amino acid 496 of the coding sequence (Phex(Jrt) also published as Phex(K496X) [Ichikawa et al., 2012]). Fgf23 mRNA expression as well as that of osteocalcin, bone sialoprotein, and matrix extracellular phosphoglycoprotein was upregulated in male mutant long bone, but that of sclerostin was unaffected. Although Phex mRNA is expressed in bone from mutant hemizygous male mice (Phex(Jrt) /Y mice), no Phex protein was detected in immunoblots of femoral bone protein. Stromal cultures from mutant bone marrow were indistinguishable from those of wild-type mice with respect to differentiation and mineralization. The ability of Phex(Jrt) /Y osteoblasts to mineralize and the altered expression levels of matrix proteins compared with the well-studied Hyp mice makes it a unique model with which to further explore the clinical manifestations of XLH and its link to FGF23 as well as to evaluate potential new therapeutic strategies. J. Cell. Biochem. 113: 2432-2441, 2012. © 2012 Wiley Periodicals, Inc.
Authors:
Celeste Owen; Frieda Chen; Ann M Flenniken; Lucy R Osborne; Shoji Ichikawa; S Lee Adamson; Janet Rossant; Jane E Aubin
Related Documents :
23955767 - A case of infliximab-induced lupus in a patient with ankylosing spondylitis: is it safe...
23024437 - Distinct phase relationships between suprachiasmatic molecular rhythms, cerebral cortex...
24377047 - Whole body microwave irradiation for improved dacarbazine therapeutical action in cutan...
22583657 - Prdx1 deficiency in mice promotes tissue specific loss of heterozygosity mediated by de...
16552067 - Deletion of the cabig1 gene reduces beta-1,6-glucan synthesis, filamentation, adhesion,...
22214847 - Cbx7 is a tumor suppressor in mice and humans.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of cellular biochemistry     Volume:  113     ISSN:  1097-4644     ISO Abbreviation:  J. Cell. Biochem.     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-05-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8205768     Medline TA:  J Cell Biochem     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2432-41     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 Wiley Periodicals, Inc.
Affiliation:
Centre For Modeling Human Disease, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, Canada M5G 1X5.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ultrasensitive detection of cellular protein interactions using bioluminescence resonance energy tra...
Next Document:  The plating of rat scar myofibroblasts on matrigel unmasks a novel phenotype; the self assembly of l...